dc.contributor | Perez-Fernandez, Oscar-Mauricio | |
dc.creator | Cantillo Manotas, Wainer | |
dc.creator | Perez-Fernandez, Oscar-Mauricio | |
dc.creator | Molano Triviño, Alejandra Patricia | |
dc.creator | Wancjer Meid, Benjamin | |
dc.date.accessioned | 2015-08-05T21:32:09Z | |
dc.date.available | 2015-08-05T21:32:09Z | |
dc.date.created | 2015-08-05T21:32:09Z | |
dc.date.issued | 2015 | |
dc.identifier | http://repository.urosario.edu.co/handle/10336/10602 | |
dc.identifier | https://doi.org/10.48713/10336_10602 | |
dc.description.abstract | Introduction: continuous renal replacement therapies (CRRTs) are an important measure to use in patients with acute kidney injury attending to the intensive care unit. Early loss of the extracorporeal circuit by coagulation is an situation that affects this group of patients.
Materials and Methods: A case and control study was conducted. Duration of study was three months. Patients underwent to CRRTs at Fundación Cardioinfantil were included. Cases were defined by patients failing to complete 72 hours of therapy because of circuit coagulation, conversely for controls (longer than 72 hours). Both groups were analyzed according to different demographic, clinical and circuit variables. Primary analysis used only the first filter and a secondary analysis included all filters.
Results: 24 patients for the primary analysis and 101 filters for secondary analysis were collected. 37.5% of the filters lasted > 72 hours and 62.5% suffer early loss of circuit. The APACHE II score (OR 0.76, p 0.003) and right femoral insertion site (OR: 0.14, p 0.007) were found protective for early dysfunction.
Discussion: although the total sample was not reached, the right femoral access was found protective, being a new finding, however further confirmation is required. The APACHE II, also protective, may correspond to a bias. Other studies to clarify these findings and determine the presence of other variables involved are needed. | |
dc.language | spa | |
dc.publisher | Universidad del Rosario | |
dc.publisher | Especialización en Medicina Interna | |
dc.publisher | Facultad de Medicina | |
dc.rights | http://creativecommons.org/licenses/by-nc-sa/2.5/co/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Abierto (Texto completo) | |
dc.rights | Atribución-NoComercial-CompartirIgual 2.5 Colombia | |
dc.rights | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización.
--------------------------------------
POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos. | |
dc.source | Eckardt K-U, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet.382(9887):158-69. | |
dc.source | James MT, Tonelli M, for the Alberta Kidney Disease N. Financial Aspects of Renal Replacement Therapy in Acute Kidney Injury. Seminars in Dialysis. 2011;24(2):215-9. | |
dc.source | De Smedt DM, Elseviers MM, Lins RL, Annemans L. Economic evaluation of different treatment modalities in acute kidney injury. Nephrology Dialysis Transplantation. 2012;27(11):4095-101. | |
dc.source | Kim IB, Fealy N, Baldwin I, Bellomo R. Premature Circuit Clotting due to Likely Mechanical Failure during Continuous Renal Replacement Therapy. Blood Purification. 2010;30(2):79-83. | |
dc.source | Cutts MWJ, Thomas AN, Kishen R. Transfusion requirements during continuous veno-venous haemofiltration: – the importance of filter life. Intensive Care Medicine. 2000;26(11):1694-7. | |
dc.source | Parienti J-J, Mégarbane B, Fischer M-O, Lautrette A, Gazui N, Marin N, et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Critical Care Medicine. 2010;38(4). | |
dc.source | Krouzecky A, Chvojka J, Sykora R, Radej J, Karvunidis T, Novak I, et al. Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy? Intensive Care Medicine. 2009;35(2):364-70. | |
dc.source | Bagshaw S, Davenport A. Cooling and reduced risk of clotting within the extracorporeal continuous renal replacement circuit. Intensive Care Medicine. 2009;35(2):195-7. | |
dc.source | Baldwin I, Bellomo R, Koch B. Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Medicine. 2004;30(11):2074-9. | |
dc.source | Baldwin I, Tan HK, Bridge N, Bellomo R. POSSIBLE STRATEGIES TO PROLONG CIRCUIT LIFE DURING HEMOFILTRATION: THREE CONTROLLED STUDIES. Renal Failure. 2002;24(6):839. | |
dc.source | Nagarik Amit P SSS, Adikey Gopal Kishan, Raman Anuradha. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy. Saudi J Kidney Dis Transpl. 2010;21(10):478 - 83. | |
dc.source | Scribner BH CJ, Buri R, Quinton W. The technique of continuous hemodialysis. Trans Am Soc Artif Intern Organs. 1960;6:88 - 103. | |
dc.source | Kidney D. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl.2012(2):1 - 138. | |
dc.source | Li PKT, Burdmann EA, Mehta RL, for the World Kidney Day Steering Committee. Acute Kidney Injury: Global Health Alert. Transplantation. 2013;95(5):653-7. | |
dc.source | Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, et al. Acute kidney injury: an increasing global concern. The Lancet.382(9887):170-9. | |
dc.source | Schissler MM, Zaidi S, Kumar H, Deo D, Brier ME, McLeish KR. Characteristics and outcomes in community-acquired versus hospital-acquired acute kidney injury. Nephrology. 2013;18(3):183-7. | |
dc.source | Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson JM, et al. Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clinical Medicine. 2013;13(3):238-88. | |
dc.source | Wehbe E, Brock R, Budev M, Xu M, Demirjian S, Schreiber Jr MJ, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation. The Journal of Heart and Lung Transplantation. 2012;31(3):244-51. | |
dc.source | Choi JS, Kim YA, Kim MJ, Kang YU, Kim CS, Bae EH, et al. Relation Between Transient or Persistent Acute Kidney Injury and Long-Term Mortality in Patients With Myocardial Infarction. The American Journal of Cardiology. 2013;112(1):41-5. | |
dc.source | Schneider A, Bellomo R, Bagshaw S, Glassford N, Lo S, Jun M, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney 47 injury: a systematic review and meta-analysis. Intensive Care Medicine. 2013;39(6):987-97. | |
dc.source | Sanchez J, Maynar J, Herrera M. Terapias continuas de depuración extrarenal (TCDE). In: Poch E, Liaño F, Gaínza FJ, editors. MANEJO DE LA DISFUNCION AGUDA DEL RIÑON, del paciente critico en la practica clinica. 1. 1 ed. Madrid: Ergon; 2011. p. 69 - 86. | |
dc.source | Davenport A, Neng K, Hertel J, Caruana R. anticoagulación. In: Daugirdas JT, editor. MANUAL DE DIALISIS. 1. 4 ed. Barcelona (España): Wolters Kluwer Health España S.A., Lippincott Williams & Wilkins; 2008 Copyrigth 2007 edicion en ingles. p. 203 - 15. | |
dc.source | Lucchi L, Ligabue G, Marietta M, Delnevo A, Malagoli M, Perrone S, et al. Activation of Coagulation During Hemodialysis: Effect of Blood Lines Alone and Whole Extracorporeal Circuit. Artificial Organs. 2006;30(2):106-10. | |
dc.source | Rebecca AC, Helen M, Ian JM, Samuel JM, Mervyn S. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Kidney International. 1999;55(4):1568-74. | |
dc.source | Gaínza FJ, Urbizu JM. Accesos vasculares, membranas y anticoagulacion extracorporea para tecnicas continuas o intermitentes en UCI. In: Poch E, Liaño F, Gaínza FJ, editors. MANEJO DE LA DISFUNCION AGUDA DEL RIÑON, del paciente critico en la practica clinica. 1. 1 ed. Madrid: Ergon; 2011. p. 55 - 68. | |
dc.source | Oudemans-van Straaten HM. Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill. Blood Purification. 2010;29(2):191-6. | |
dc.source | del Castillo J, Lopez-Herce J, Cidoncha E, Urbano J, Mencia S, Santiago M, et al. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Critical Care. 2008;12(4):R93. | |
dc.source | instname:Universidad del Rosario | |
dc.source | reponame:Repositorio Institucional EdocUR | |
dc.subject | Terapia continúa de reemplazo renal | |
dc.subject | Circuito extracorpóreo | |
dc.subject | Citrato | |
dc.title | Factores asociados con la duración del circuito extracorpóreo en terapias continúas de reemplazo renal en la Fundación Cardioinfantil | |
dc.type | masterThesis | |